Cite
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis
MLA
Gabriele Gugliotta, et al. Ponatinib Treatment in Chronic Myeloid Leukemia Cell Lines Targets Aurora Kinase A/FOXM1 Axis. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7224ebb09522e988cc6c252b770de0bd&authtype=sso&custid=ns315887.
APA
Gabriele Gugliotta, Gianantonio Rosti, Sara De Santis, Manuela Mancini, Fausto Castagnetti, Simona Soverini, Giovanni Martinelli, Cecilia Monaldi, Michele Cavo, Maria Alessandra Santucci, Luana Bavaro, & Margherita Martelli. (2020). Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis.
Chicago
Gabriele Gugliotta, Gianantonio Rosti, Sara De Santis, Manuela Mancini, Fausto Castagnetti, Simona Soverini, Giovanni Martinelli, et al. 2020. “Ponatinib Treatment in Chronic Myeloid Leukemia Cell Lines Targets Aurora Kinase A/FOXM1 Axis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7224ebb09522e988cc6c252b770de0bd&authtype=sso&custid=ns315887.